Wrensch Margaret, Minn Yuriko, Chew Terri, Bondy Melissa, Berger Mitchel S
Department of Epidemiology and Biostatistics University of California at San Francisco, San Francisco, CA 94143, USA.
Neuro Oncol. 2002 Oct;4(4):278-99. doi: 10.1093/neuonc/4.4.278.
The purpose of this review is to provide a sufficiently detailed perspective on epidemiologic studies of primary brain tumors to encourage multidisciplinary etiologic and prognostic studies among surgeons, neuro-oncologists, epidemiologists, and molecular scientists. Molecular tumor markers that predict survival and treatment response are being identified with hope of even greater gains in this area from emerging array technologies. Regarding risk factors, studies of inherited susceptibility and constitutive polymorphisms in genes pertinent to carcinogenesis (for example, DNA repair and detoxification genes and mutagen sensitivity) have revealed provocative findings. Inverse associations of the history of allergies with glioma risk observed in 3 large studies and reports of inverse associations of glioma with common infections suggest a possible role of immune factors in glioma genesis or progression. Studies continue to suggest that brain tumors might result from workplace, dietary, and other personal and residential exposures, but studies of cell phone use and power frequency electromagnetic fields have found little to support a causal connection with brain tumors; caveats remain. The only proven causes of brain tumors (that is, rare hereditary syndromes, therapeutic radiation, and immune suppression giving rise to brain lymphomas) account for a small proportion of cases. Progress in understanding primary brain tumors might result from studies of well-defined histologic and molecular tumor types incorporating assessment of potentially relevant information on subject susceptibility and environmental and noninherited endogenous factors (viruses, radiation, and carcinogenic or protective chemical exposures through diet, workplace, oxidative metabolism, or other sources). Such studies will require the cooperation of researchers from many disciplines.
本综述的目的是提供关于原发性脑肿瘤流行病学研究足够详细的观点,以鼓励外科医生、神经肿瘤学家、流行病学家和分子科学家开展多学科病因学和预后研究。预测生存和治疗反应的分子肿瘤标志物正在被识别出来,人们希望新兴的阵列技术能在这一领域带来更大的收获。关于危险因素,对与致癌作用相关基因(例如DNA修复和解毒基因以及诱变敏感性)的遗传易感性和组成型多态性的研究已经揭示了一些引人注目的发现。在3项大型研究中观察到过敏史与胶质瘤风险之间的负相关,以及胶质瘤与常见感染之间负相关的报道,提示免疫因素在胶质瘤发生或进展中可能发挥作用。研究继续表明,脑肿瘤可能源于工作场所、饮食以及其他个人和居住环境暴露,但对手机使用和工频电磁场的研究几乎没有发现支持其与脑肿瘤存在因果关系的证据;仍需注意一些问题。唯一已证实的脑肿瘤病因(即罕见的遗传综合征、治疗性放疗以及导致脑淋巴瘤的免疫抑制)仅占病例的一小部分。对原发性脑肿瘤认识的进展可能源于对明确的组织学和分子肿瘤类型的研究,这些研究纳入了对受试者易感性以及环境和非遗传内源性因素(病毒、辐射以及通过饮食、工作场所、氧化代谢或其他来源的致癌或保护性化学暴露)潜在相关信息的评估。此类研究将需要多学科研究人员的合作。